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Abstract  Congenital  fiber-type  disproportion  myopathy  causes  impaired  muscle  maturation
or development.  It  is characterized  by  moderate  to  severe  hypotonia  and  generalized  muscle
weakness at  birth  or  during  the first  year  of  life,  especially  in the  lower  extremities.  It  is
inherited as  an  autosomal  recessive,  dominant  and  X-linked.  It is diagnosed  by clinical  data
confirmation,  generalized  hypotonia  and  a  muscle  biopsy  in which  muscle  fibers  type  I are
smaller in caliber,  12%  smaller  than  those  of  type  II and  type  I fibers  are  more  common  than
type II. Treatment  is multidisciplinary.
The  following  describes  the  case  of  a patient  who  was  born  in the ‘‘Dr.  José  Eleuterio
González’’  University  Hospital  in Monterrey,  N.L,  who  presented  clinical  and  muscle  biopsy
compatible with  this myopathy.
©  2014  Universidad  Autónoma  de  Nuevo  León.  Published  by  Masson  Doyma  México  S.A.  All  rights
reserved.
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Introduction
Within  congenital  myopathies  classifications,  there  are
myopathies  with  alterations  in  muscle  maturation  and/or
development.  One  of  these  myopathies  is  congenital  fiber-
type  disproportion,  which  is  characterized  by generalized
muscle  weakness  at  birth or  during  the  baby’s  first  year,
mainly  in the extremities.1,2
It was  first  described  by  Brooke  and Engel1,3 in a study
of  the morphology  of children’s  biopsies.  It is  a rare
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entity,  which  occurs  in 1 in  every  50,000  live  births.4 All
body  musculature  is  affected.  However,  the muscles  in
the  lower  extremities  are usually  more  altered  than  the
upper  extremities;  thus  the electromyography  reports  a
myopathic  process,  although  in others  there  is  a  neurogenic
component.11,13 Some  cases  with  a  longer  evolution  time
show  mild  sclerosis5 and  there  have  been  reports  of impor-
tant  respiratory  alterations,  severe  brain  damage  and heart
diseases.1,7,8 In  a  few  cases an  association  of  skeletal  and
articular  alterations  has  been  observed.9,10
Clinical case
The  mother  of  the baby  boy  was  a  25-year-old  woman,  pre-
viously  healthy,  secondary  school  completed,  without  drug
addictions,  living  together  with  her  partner.  The  father  was
a  30-year-old  man,  healthy,  without  any  relevant  history.
The  newborn  had  two  other  brothers,  a 4-year-old  and a
7-year-old,  both  healthy.
The  product  of a fourth  pregnancy,  the mother  had had
two  C-sections  performed  and suffered  a miscarriage  when
she  was  9 weeks  pregnant.  She completed  a normal  preg-
nancy,  with  folic acid, iron  intake,  as  well  as  supplementary
multivitamins  for  the first  month  of  pregnancy,  prenatal
control  with  8  visits  to the University  Hospital  without  pre-
senting  abnormalities.
Born  by  elective  C-section  due  to  the history  of  two  pre-
vious  C-sections  at 38.4  weeks  of  gestation,  with  an  Apgar
score  of  2/6  because  it  was  found  to  be  acrocyanotic,  flac-
cid,  no  respiratory  effort,  and  with  a heart  rate  of 80  bpm.
He  is  given  2  positive  pressure  ventilation  cycles,  improv-
ing  hear  rate,  but  not  respiratory  effort,  and  was  therefore
intubated  and  left  under  mechanical  ventilation  and  moved
to  the  Neonatal  Intensive  Care  Unit.
During  physical  examination:  Weight:  3070  g,  located  in
the  50th  percentile,  size:  50  cm, in the  50th  percentile,
cephalic  perimeter:  (CP)  36  cm,  in  the 50th  percentile,  myo-
pathic  facies  with  an  elongated  face,  symmetrical  eyes  and
a  bilateral  ptosis,  presenting  red  reflex,  permeable  nostrils,
proper  ear  implantation,  an ogival  palate  and  a  tented  upper
lip.  Neck:  retrognathial,  short,  round.  Thorax: no respiratory
effort,  without  deformities,  normal  lung  fields,  holosystolic
murmur  grade  3--4 detected.  The  abdomen  was  soft,  pal-
pable  without  pain,  and  free  of visceromegaly,  an umbilical
cord,  2 arteries  and a vein.  Male  genitalia:  Tanner 1, right
cryptorchidie,  with  the right  testicle  in the  inguinal  canal
and  the  left  testicle  in  the scrotal  bag. The  extremities:  gen-
eralized  hypotonia,  no  response  to  painful  stimulus,  absence
of  muscle  tone,  deep  tendon  reflexes  absent,  rigid  right
clubfoot.
Upon  admission,  gasometry  and  asphyctic  profile  on
admission  and  at  24  h  (due  to  perinatal  asphyxia  suspicion)
were  normal  and  a  transfontanellar  ultrasound  (TFUS)  and
brain  MRI  were  performed  and  were  also  normal  (Fig.  1).
No  infection-compatible  alterations  were  found,  as well  as
the  metabolic  panel  (with  electrolytes)  and  the  metabolic
screening  were also  normal.  An  electrocardiogram  was  per-
formed  due  to  the  presence  of  ICT  in 0.62  (Fig.  2)  and  due  to
the  holosystolic  murmur  grade  II/VI  detecting  an interven-
tricular  communication  of 2  mm,  mild  tricuspid  insufficiency,
Figure  1 Normal  MRI.
a persistence  of  a patent  ductus  arteriosus  of  1.4  mm  and  an
oval  foramen  without  hemodynamic  repercussions.
We  referred  the patient  to the  Genetics  Department  who
evaluated  the patient’s  genealogical  tree,  without  finding
any  history  of  neuromuscular  diseases  in any  of  the first-
degree  relatives  or  extended  family,  thus  classifying  this
as  an  isolated  case.  Furthermore,  they  requested  a genetic
mutations  study;  however,  the  family did not have  the  eco-
nomic  resources  to  have it done.
Due  to  the  newborn’s  hypotonic  diagnosis,  a muscle
biopsy,  lab  tests  and  normal  imagining  of the right  quadri-
ceps  were  performed,  confirming  the congenital  fiber-type
disproportion  diagnosis.
The  sample  was  divided  into  two  parts; the first  part
was  cut  by  freezing  it and  processed  following  standard
Figure  2  Cardiothoracic  index  at 0.62.
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Cross-section, NADH-tr
Type I fibers dark and type II clear.
ATPasa, cross-section Ph 9.4
Type I fibers clear and type II dark.
Cross-section, H-E M.O.A.R., Toluidine blue Cross-section, modif. Tric. Gomori
Figure  3  Type  I  fibers  are dark  and  small  in  all the  cuts  except  the  ATPasa  cross-section,  where  type  I fibers  are  small,  but  clear.
Type I fibers  are  atrophic.
Type  II fibers  are  clear  and  hypertrophic,  with  the exception  of  the  ATPasa  cross-section,  where  they  are hypertrophic  but  dark.
and  special  techniques  for its  morphological,  histochemi-
cal  and  enzymatic  analyses,  applying  H&E stains,  a modified
Gomori  trichrome  and  ATPase  reactions  at pH  4.3,  4.6
and  9.4,  Nicotinamide  dinucleotide  and  adenine-tetrazolium
reductase  (NADH-tr).  In  addition,  we conducted  a mor-
phological  study  using  light  microscopy  and  high-resolution
optics  microscopy.  A  morphometric  analysis  was  conducted
on  type-I  and  type-II  fibers.  Findings  showed  the following:
it  was  determined  that,  regarding  type-I  fibers,  20%  of  them
were  within  the  normal  interval  (10--15.4  m)  with  an  aver-
age  of  6.9 m  (normal  of  12.7  m) and a  variable  coefficient
of  449  (normal  up  to  250)  due  to  the 80%  of  atrophic  fibers,
with  a  very  elevated  atrophy  coefficient  of  1,350 (normal  up
to  150).  For  type-II  fibers,  the average  was  15.4  m (normal
10.9  m)  with  just 38%  of  fibers  within  the  normal inter-
val  (7.7--14.1  m),  the variable  coefficient  does  not exceed
the  limit  value  {241 (normal  up  to  250)}  despite  the high
percentage  of  hypertrophic  fibers  (62%)  but  the hypertro-
phy  coefficient  is  very  elevated  {600  (normal  up  to  400)}
(Fig.  3).
Discussion
Congenital  fiber-type  disproportion  myopathy,  as  displayed
in  our  patient  in  this  case,  is  determined  by  the uneven-
ness  in  the  size  of  both types  of muscle  fibers,  where  type-I
fibers  are  much  smaller,  and  type-II  fibers  are  too  large.1,2
According  to  the study  by  Brooke  and  Engel  of the  morphol-
ogy  of  biopsies,  the  entity  is  based  histopathologically  in  a
threshold  of  12%  of unevenness  in fiber  sizes  to define  the
group.13
Our  patient’s  case  is  relevant  because  congenital  fiber-
type  disproportion  myopathy  is  a rare  entity,  which
according  to medical  literature  occurs  only in  1:50,000
live  births.3,13 The  most  common  clinical  manifestations  in
50--75%  of  cases  are  moderate  to  severe  hypotonia  (floppy
babies),  general  muscle  weakness  at birth or  during the
first  year,  especially  in the lower  extremities,  and  absence
of  deep  tendon  reflexes,  which  the patient  displayed  in
our  case,  normal  or slightly  increased  creatine  kinase  (CK),
normal  intelligence,  as  well  as  normal  electromyography
or  myopathic  pattern.3,6 Common  clinical  manifestations,
which  are present  in 10--50%  of  cases  are:  myopathic  facies
with  an elongated  face,  an ogival  palate,  a  tented  upper
lip  and  light  to  severe  respiratory  problems,  all  of  which
were  found  in our  patient,  difficulty  feeding,  ophthalmo-
plegia,  contractures,  scoliosis,  lordosis  and  laxity.11,12 The
less  frequent  manifestations,  present  in less  than  10%  of
cases  are:  cardiac  involvement,  cognitive  impairment  and
cryptorchidism,  which  was  present  in our  clinical  case.3,6
It is  a genetically  heterogeneous  disease,  which in
inherited  in an autosomal  recessive  manner,  dominant  and
with  isolated  cases.1,2,9,12 To  date,  mutations  in  six genes
have  been  identified:  ACTA1  (6%),  MYH7  (unknown),  RYR1
(10--20%),  SEPN1  (rare),  TPM2  (rare)  and  TPM3 (20--25%).16
During  the  muscular  biopsy,  we  found  type I  muscular
fibers  of  a smaller  caliber  (12%  smaller)  than the  type  IIs,
which  were  found  to  be hypertrophic.  And in  the  same  way
we  found  the type  I  or  atrophic  fibers,  we  also  found a
greater  number  of  type  II  or  hypertrophic14,15 fibers,  which
were  found in the immunohistological  report  of  the muscular
biopsy  performed  in the  case  of  our  patient.
The  best threshold  for  the level  of  disproportion  of
muscle  fibers  necessary  to  make  a diagnosis  is  still  under
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discussion,  but  there  is  a general  consensus  that  it  should
be  equal  to  or  greater  than  12%. The  prenatal  diagnosis  is
made  by  analyzing  DNA extracted  from  fetal  cells  with  a
chorionic  villus  sampling  at  10  or  12  weeks  of gestation  and
an amniocentesis  at 15  to  18  weeks  of  gestation,  where  the
mutation  in some  of  the  3 genes  causing  the  disease  can  be
found.3,13
The  treatment  is  multidisciplinary,  with  physical  rehabil-
itation  and  treatment  of  complications  such as  respiratory
difficulties,  joint  alterations,  weakness  and swallowing
difficulties.3,13
The  prognosis  depends  on  the degree  of  hypotonia  as
well  as respiratory  and cardiac  involvement.  Ophthalmople-
gia,  ptosis,  a bulbous  or  weak  face,  severe  weakness  in  the
extremities  and  respiratory  weakness  have  been described
as  factors  for  a negative  prognosis.3,11,13
The  presentation  of this  clinical  case  is  important,  as  it
deals  with  an  infrequent  entity,  which represents  a  diag-
nostic  and  therapeutic  challenge  in our line  of  work.  It  is
important  to  get  to  know  the  clinical  manifestations,  how
to  arrive  at  a  diagnosis,  and  understand  the complications
which  may  arise  in  these patients,  to  provide  adequate
treatment,  prevent  complications,  and  offer  a  better  quality
of  life.  Additionally,  the presentation  of this case  opens  the
doors  to  more  diagnostic  possibilities  which  we  should  look
forward  to cope  with  a  newborn  with  generalized  hypotonia.
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